Alzheimer's wonder drug could give patients four more years of good health
Share this @internewscast.com

Groundbreaking new Alzheimer’s treatment could give patients four years of better health. Patients who participated in the trial of the drug lecanemab also saw improvements in their cognitive function. Last year, the treatment was licensed for use in the UK after trials demonstrated its ability to slow the progress of the disease. 

The results show that, over 18 months, it slowed the progression of Alzheimer’s by 5.7 months. 478 patients then stayed on the drug for four years, which found an average delay of almost 11 months before their disease worsened to the next stage, The Telegraph has revealed. A staggering 69% of patients with low levels of tau – the protein that builds up as Alzheimer’s progresses – saw no decline at all over four years. Over half (56%) of those in the same group also saw major improvements in their cognitive scores. 

Patients with mild dementia usually see scores rise by between one and two points each year on the scoring systems used to track Alzheimer’s. However, across the entire group trialling the drug, decline slowed to just 1.75 points over four years. 

“The thing I really focus on is the time saved. You will get worse over time, but it will take longer to get there,” Prof Christopher Van Dyck, the director of the Alzheimer’s Research unit at the Yale school of medicine and the study leader, said. 

He added that the findings argued the case for starting early treatment of the disease due to it having the best results in people with the lowest pathology. 

Experts have since said the new treatments could “meaningfully change the course of the disease”, and not just slow decline. 

A separate trail of the similar drug donanemab also showed promising results. Patients were tracked for three years, with the treatment given for just 18 months.

The findings showed that those on the drug had gained between six and 12 months before the disease progressed further, compared to those not on the treatment. 

Dr Sheona Scales, the director of research at Alzheimer’s Research UK, told The Telegraph that, while the findings offered renewed hope, research is ongoing.

“This is the first wave of disease-modifying treatments for Alzheimer’s and, while the progress is encouraging, there are still many pieces of the puzzle we don’t yet have,” she said. 

Share this @internewscast.com
You May Also Like

Unexpected Health Perks of Meghan Markle’s Key Ingredient in Netflix Series

In the most recent season of the Netflix hit, With Love, Meghan,…

Hair Loss Sufferers Amazed by Hair Growth Boost from Beauty Bundle

Experiencing hair thinning and loss can significantly impact one’s confidence, with solutions…

The Critical Healthcare Shortage Endangering Millions of American Lives

Almost two-thirds of doctors believe the United States is facing a shortage…

What Doctors Might Not Share: A Heart Surgeon’s Simple Daily Exercise for Lifesaving Health Benefits

Swapping thirty minutes of sitting for a brisk daily walk can significantly…

Hostess Issues Recall of Popular Snack Due to Possible Mold Contamination Concerns

Hostess Ding Dongs are being recalled over fears they could be contaminated…

Revolutionary Sportswear Designed to Keep Teen Girls Active with Improved Comfort

A recently developed ergonomic PE kit aims to boost participation in sports…

Map Highlights Over 1,300 Toxic Locations in the US with Cancer-Causing Chemicals Contaminating the Soil

Thousands of Americans are living in the direct path of invisible toxic…

Potential Autism Advancement: 40% of Children with Autism Deficient in Essential Nutrient

Millions of children with autism could unknowingly be suffering key vitamin deficiencies,…

Doctor Reveals Six Unexpected Gut Symptoms You Shouldn’t Ignore

Skin irritation, unexpected weight changes, and new food intolerances might indicate an…

“Why Hospice May Seem Intimidating But Offers Us More Time”

The word “hospice” often conjures up images of people living out their…

Malawi Faces Imminent TB Drug Shortage Following Aid Reductions from US, UK, and Others

Malawi is facing a critical shortage of tuberculosis drugs, with health officials…

FDA Approves New COVID-19 Vaccines in the US with Eligibility Restrictions

The US Food and Drug Administration (FDA) has approved updated Covid-19 vaccines…